Varex Imaging (NASDAQ:VREX – Get Free Report) and Glucose Health (OTCMKTS:GLUC – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Varex Imaging and Glucose Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Varex Imaging | 1 | 1 | 2 | 0 | 2.25 |
| Glucose Health | 0 | 0 | 0 | 0 | 0.00 |
Varex Imaging currently has a consensus price target of $16.17, suggesting a potential upside of 50.67%. Given Varex Imaging’s stronger consensus rating and higher probable upside, equities analysts plainly believe Varex Imaging is more favorable than Glucose Health.
Risk and Volatility
Profitability
This table compares Varex Imaging and Glucose Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Varex Imaging | -7.92% | 8.43% | 3.66% |
| Glucose Health | -108.70% | N/A | N/A |
Valuation and Earnings
This table compares Varex Imaging and Glucose Health”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Varex Imaging | $844.60 million | 0.53 | -$70.30 million | ($1.64) | -6.54 |
| Glucose Health | $380,000.00 | 20.06 | -$320,000.00 | ($0.03) | -12.42 |
Glucose Health has lower revenue, but higher earnings than Varex Imaging. Glucose Health is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Varex Imaging beats Glucose Health on 8 of the 12 factors compared between the two stocks.
About Varex Imaging
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
